Anosodiaphoria

From WikiMD's WELLNESSPEDIA


Anosodiaphoria
Synonyms
Pronounce N/A
Specialty Neurology
Symptoms Lack of emotional response to illness
Complications N/A
Onset
Duration
Types
Causes Brain damage, often due to stroke
Risks
Diagnosis Clinical assessment
Differential diagnosis Anosognosia, neglect
Prevention N/A
Treatment
Medication
Prognosis
Frequency
Deaths N/A


Anosodiaphoria Anosodiaphoria is a neurological condition characterized by a lack of emotional response or concern towards one's own illness or disability. This condition is often associated with hemiplegia or other forms of brain damage, particularly following a stroke.

Etymology[edit]

The term "anosodiaphoria" is derived from the Greek words "a-" meaning "without," "nosos" meaning "disease," and "diaphora" meaning "difference." It was first introduced by the French neurologist Joseph Babinski in the early 20th century.

Clinical Features[edit]

Individuals with anosodiaphoria are aware of their medical condition but exhibit an indifferent attitude towards it. This is in contrast to anosognosia, where the individual is unaware of their condition. Anosodiaphoria is often observed in patients with right hemisphere brain lesions.

Associated Conditions[edit]

Anosodiaphoria is frequently associated with:

Diagnosis[edit]

Diagnosis of anosodiaphoria involves clinical assessment by a neurologist or neuropsychologist. It is important to differentiate anosodiaphoria from other conditions such as depression or anosognosia.

Treatment[edit]

There is no specific treatment for anosodiaphoria. Management typically focuses on rehabilitation and addressing the underlying neurological condition. Psychological support and counseling may be beneficial for some patients.

Prognosis[edit]

The prognosis for anosodiaphoria varies depending on the underlying cause and the extent of brain damage. Some patients may show improvement over time, while others may continue to exhibit anosodiaphoria.

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.